Chemicals & Advanced Materials Global On demand · 24-48h

Global Ethyl Benzoylacetate Market Strategic Research Report

Global Ethyl Benzoylacetate Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Ethyl Benzoylacetate Market
$69.452025
5.1%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Industrial Grade (90%–<98%), High-Purity Grade (≥98%)

By Application: Pharmaceutical Intermediate, Agrochemical Intermediate, Flavor and Fragrance, Dye and Pigment, Organic Synthesis, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Arxada, Vigon International, Jiangxi Keyuan Biopharm, Luotian Xinpusheng Pharmaceutical, Yancheng Chunzhu Aroma, Taizhou Runsun Chemical, Hunan Huateng Pharmaceutical, Unilong Industry

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 87 pages
Market size 2025
$69.45
Million USD
Forecast CAGR
5.1%
2025-2032
Forecast 2032
$98.4
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Ethyl Benzoylacetate market size is predicted to grow from US$ 69.45 million in 2025 to US$ 98 million in 2032; it is expected to grow at a CAGR of 5.1% from 2026 to 2032.

In 2025, global sales volume of Ethyl Benzoylacetate was approximately 2,500 tonnes, with a weighted average selling price of around USD 27 per kilogram at the manufacturer level. Major manufacturers generally recorded gross margins of approximately 25%–38%.

Ethyl Benzoylacetate is an aromatic β-keto ester with the CAS number 94-02-0 and molecular formula C₁₁H₁₂O₃. It typically appears as a colorless to pale yellow liquid at room temperature. The molecule contains both an aromatic ketone group and an ethyl carboxylate group. The active methylene group located between the two carbonyl groups can undergo alkylation, acylation, condensation, cyclization, and halogenation reactions. It also exhibits pronounced keto–enol tautomerism, making it an important intermediate for the synthesis of aromatic and heterocyclic fine chemicals.

Ethyl Benzoylacetate is primarily manufactured through an ester condensation route or an acyl chloride acylation route, with commercial products generally available in purities ranging from 90% to 98% and above. Its principal upstream materials include ethyl acetoacetate, benzoyl chloride, ethyl benzoate, sodium ethoxide, relevant solvents, and acid–base auxiliaries. Major downstream applications include pharmaceutical intermediate, agrochemical intermediate, flavor and fragrance, dye and pigment, and organic synthesis. Future market growth is expected to be driven mainly by expanding demand from the pharmaceutical, agrochemical, and other fine chemical sectors, while the share of high-purity and customized products is projected to increase gradually.

This report presents a comprehensive overview of the global Ethyl Benzoylacetate market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Industrial Grade (90%–<98%)
  • High-Purity Grade (≥98%)

Segment by Synthesis Route

  • Ester Condensation Route
  • Acyl Chloride Acylation Route

Segment by Application

  • Pharmaceutical Intermediate
  • Agrochemical Intermediate
  • Flavor and Fragrance
  • Dye and Pigment
  • Organic Synthesis
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Ethyl Benzoylacetate market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Pharmaceutical Intermediate, Agrochemical Intermediate, Flavor and Fragrance evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Ethyl Benzoylacetate Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.1%
Regional growth momentum
Market share by segment
Key metrics
Base value
$69.45
2025
Forecast
$98.4
2032
CAGR
5.1%
2025–2032
Régions
5
global
Key companies
ArxadaVigon InternationalJiangxi Keyuan BiopharmLuotian Xinpusheng PharmaceuticalYancheng Chunzhu AromaTaizhou Runsun ChemicalHunan Huateng PharmaceuticalUnilong Industry
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Industrial Grade (90%–<98%)High-Purity Grade (≥98%)
By Application
Pharmaceutical IntermediateAgrochemical IntermediateFlavor and FragranceDye and PigmentOrganic SynthesisOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Industrial Grade (90%–<98%)
  • 3.1.3 High-Purity Grade (≥98%)
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Pharmaceutical Intermediate
  • 4.1.3 Agrochemical Intermediate
  • 4.1.4 Flavor and Fragrance
  • 4.1.5 Dye and Pigment
  • 4.1.6 Organic Synthesis
  • 4.1.7 Other
  • 4.1.8 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Arxada
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Vigon International
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Jiangxi Keyuan Biopharm
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Luotian Xinpusheng Pharmaceutical
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Yancheng Chunzhu Aroma
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Taizhou Runsun Chemical
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Hunan Huateng Pharmaceutical
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Unilong Industry
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Ethyl Benzoylacetate market size?
The global Ethyl Benzoylacetate market is estimated at US$ 69.45 million in 2025 (base year) and is projected to reach US$ 98 million by 2032.
What growth rate is expected for the Ethyl Benzoylacetate market through 2032?
The market is expected to grow at a CAGR of 5.1% from 2026 to 2032, expanding from US$ 69.45 million in 2025 to US$ 98 million in 2032, roughly 1.4 times its base-year value.
How is Ethyl Benzoylacetate defined?
In 2025, global sales volume of Ethyl Benzoylacetate was approximately 2,500 tonnes, with a weighted average selling price of around USD 27 per kilogram at the manufacturer level. Major manufacturers generally recorded gross margins of approximately 25%–38%.
How is the Ethyl Benzoylacetate market segmented by type?
By type, the market is segmented into Industrial Grade (90%–<98%) and High-Purity Grade (≥98%).
What are the key applications of Ethyl Benzoylacetate?
Key applications covered include Pharmaceutical Intermediate, Agrochemical Intermediate, Flavor and Fragrance, Dye and Pigment, Organic Synthesis and Other.
Which companies are profiled in the Ethyl Benzoylacetate market report?
Key players profiled include Arxada, Vigon International, Jiangxi Keyuan Biopharm, Luotian Xinpusheng Pharmaceutical, Yancheng Chunzhu Aroma, Taizhou Runsun Chemical, Hunan Huateng Pharmaceutical and Unilong Industry.
What geographies does the Ethyl Benzoylacetate market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Ethyl Benzoylacetate?
Future market growth is expected to be driven mainly by expanding demand from the pharmaceutical, agrochemical, and other fine chemical sectors, while the share of high-purity and customized products is projected to increase gradually.
Who should buy the Ethyl Benzoylacetate market report?
The report is intended for manufacturers and solution providers, distributors and end users in Pharmaceutical Intermediate, Agrochemical Intermediate and Flavor and Fragrance, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Ethyl Benzoylacetate market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.